Gemphire to Present at the Oppenheimer Annual Healthcare Conference and the H.C. Wainwright NASH Investor Event

Thursday, March 16, 2017 7:52 PM UTC

LIVONIA, Mich., March 16, 2017 -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and NASH, today announced that management will provide a corporate update at the Oppenheimer 27^th Annual Healthcare Conference, taking place March 21-22 at the Westin New York Grand Central Hotel, and will also present at the 1^st Annual H.C. Wainwright NASH Investor Event, taking place April 3, 2017, at the St. Regis Hotel in New York City.

*Oppenheimer & Company 27th Annual Healthcare Conference*
Date:	Tuesday, March 21
Time:	3:20pm Eastern Time
Location:	Track 3, Westin New York Grand Central Hotel.
Webcast:	https://www.veracast.com/webcasts/opco/healthcare2017/18113422476.cfm

*H.C. Wainwright NASH Investor Event*
Date:	Monday, April 3
Time:	9:40am Eastern Time
Location:	Versailles Room, St Regis Hotel, New York City.

About Gemphire
Gemphire is a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH. We are focused on providing new treatment options for cardiometabolic diseases through our complementary, convenient, cost-effective product candidate gemcabene as add-on to the standard of care especially statins that will benefit patients, physicians, and payors. Gemphire has initiated 3 clinical trials for homozygous familial hypercholesterolemia (HoFH), heterozygous familial hypercholesterolemia (HeFH)/atherosclerotic cardiovascular disease (ASCVD), and severe hypertriglyceridemia (SHTG) under NCT02722408, NCT02634151, and NCT02944383, respectively with a fourth planned trial in NASH. Please visit www.gemphire.com for more information.

Contact:

Andrew McDonald, Ph.D.
LifeSci Advisors, LLC
(646) 597-6987

Jeff Mathiesen, CFO
Gemphire Therapeutics Inc.
(734)-245-1700

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Gemphire to Present at the Oppenheimer Annual Healthcare Conference and the H.C. Wainwright NASH Investor Event

Editor's Picks

Welcome to EconoTimes